F.D.A. Approves New Treatment for Early Alzheimer’s

Health
By BY PAM BELLUCK from NYT Health https://ift.tt/KWVLev7
via IFTTT Drugs (Pharmaceuticals), Alzheimer's Disease, Clinical Trials, Medicare, Placebos, Labeling and Labels (Product), Aduhelm (Drug), your-feed-healthcare The drug, Leqembi, may modestly slow cognitive decline in early stages of the disease but carries some safety risks. Still, data suggests it is more promising than the small number of other available treatments.

Comments

Post a Comment

Popular posts from this blog

Should the Autism Spectrum Be Split Apart?

Image
Health By Azeen Ghorayshi from NYT Health https://ift.tt/ZX2NkH3 via IFTTT Autism, Intellectual Disabilities, Asperger's Syndrome, Special Education, Mental Health and Disorders, Children and Childhood, United States Politics and Government, Medicine and Health Families of people with severe autism say the repeated expansion of the diagnosis pushed them to the sidelines. A new focus on the disorder has opened the way for them to argue their cause.
Read more

The Young Women Grappling With an ‘Old Man’s Disease’

Image
Health By Roni Caryn Rabin and Lucy Lu from NYT Health https://ift.tt/rBAEXmJ via IFTTT your-feed-science, Amyotrophic Lateral Sclerosis, Women and Girls, Age, Chronological, Parties (Social), audio-positive-happy, audio-negative-sad, Disabilities, Travel and Vacations, Content Type: Personal Profile Diagnosed with A.L.S., they traded stories, drank tequila and made grim jokes at a unique annual gathering on Cape Cod.
Read more